• 1
    Palace J, Lang B. Epilepsy: an autoimmune disease? J Neurol Neurosurg Psychiatry 2000; 69: 7114.
  • 2
    Aarli JA. Epilepsy and the immune system. Arch Neurol 2000; 57: 168992.
  • 3
    Rogers SW, Andrews PI, Gahring LC et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994; 265: 64851.
  • 4
    Van Engelen BG, Renier WO, Weemaes CM, Gabreels FJ, Meinardi H. Immunoglobulin treatment in epilepsy, a review of the literature. Epilepsy Res 1994; 19: 18190.
  • 5
    Duse M, Notarangelo LD, Tiberti S, Menegati E, Plebani A, Ugazio AG. Intravenous immune globulin in the treatment of intractable childhood epilepsy. Clin Exp Immunol 1996; 104 (Suppl. 1):716.
  • 6
    Seager J, Jamison DL, Wilson J, Hayward AR, Soothill JF. IgA deficiency, epilepsy, and phenytoin treatment. Lancet 1975; 2: 6325.
  • 7
    Aarli JA. Changes in serum immunoglobulin levels during phenytoin treatment of epilepsy. Acta Neurol Scand 1976; 54: 42330.
  • 8
    Gilhus NE, Aarli JA. The reversibility of phenytoin-induced IgA deficiency. J Neurol 1981; 226: 5361.
  • 9
    Gilhus NE, Lea T. IgG subclasses in epileptic patients treated with phenytoin. J Neurol 1989; 236: 14952.
  • 10
    Gilhus NE, Strandjord RE, Aarli JA. The effect of carbamazepine on serum immunoglobulin concentrations. Acta Neurol Scand 1982; 66: 1729.
  • 11
    Gilhus NE, Lea T. Carbamazepine: effect on IgG subclasses in epileptic patients. Epilepsia 1988; 29: 31720.
  • 12
    Pacifici R, Paris L, Di Carlo S, Pichini S, Zuccaro P. Immunologic aspects of carbamazepine treatment in epileptic patients. Epilepsia 1991; 32: 1227.
  • 13
    Basaran N, Hincal F, Kansu E, Ciger A. Humoral and cellular immune parameters in untreated and phenytoin- or carbamazepine-treated epileptic patients. Int J Immunopharmacol 1994; 16: 10717.
  • 14
    Garzon P, Gonzalez-Cornejo S, Roman-Maldonado S, Navarro-Ruiz A. Valproic acid and phenytoin effects on serum proteins and immunoglobulins of epileptic patients. General Pharmacol 1985; 16: 4113.
  • 15
    Bostantjopoulou S, Hatzizisi O, Argyropoulou O et al. Immunological parameters in patients with epilepsy. Funct Neurol 1994; 9: 115.
  • 16
    Hemingway C, Leary M, Riordan G, Schlegal B, Walker K. The effect of carbamazepine and sodium valproate on the blood and serum values of children from a third-world environment. J Child Neurol 1999; 14: 7513.
  • 17
    Peters ACB, Brouwer OF, Geerts AT, Arts WFM, Stroink H, Van Donselaar CA. Randomized prospective study of early discontinuation of antiepileptic drugs in children with epilepsy. Neurology 1998; 50: 72430.
  • 18
    Stroink H, Brouwer OF, Arts WFM, Geerts AT, Peters ACB, Van Donselaar CA. The first unprovoked, untreated seizure in childhood: a hospital based study of the accuracy of the diagnosis, rate of recurrence, and long term outcome after recurrence. The Dutch Study of Epilepsy in Childhood. J Neurol Neurosurg Psychiatry 1998; 64: 595600.
  • 19
    Arts WFM, Geerts AT, Brouwer OF, Peters ACB, Stroink H, Van Donselaar CA. The early prognosis of epilepsy in childhood: the prediction of a poor outcome. The Dutch Study of Epilepsy in Childhood. Epilepsia 1999; 40: 72634.
  • 20
    Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981; 22: 489501.
  • 21
    Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 38999.
  • 22
    Commission on Epidemiology and Prognosis ILAE. Guidelines for epidemiologic studies on epilepsy. Epilepsia 1993; 34: 5926.
  • 23
    Jol-Van der Zijde CM, Labadie J, Vlug A, Radl J, Vossen JM, Van Tol MJ. Dot-immunobinding assay as an accurate and versatile technique for the quantification of human IgG subclasses. J Immunol Meth 1988; 108: 195203.
  • 24
    Cejka J, Mood DW, Kim CS. Immunoglobulin concentrations in sera of normal children: quantitation against an international reference preparation. Clin Chem 1974; 20: 6569.
  • 25
    Central Laboratory of the Netherlands Red Cross Blood Transfusion Service (CLB).Vademecum Diagnostic Research: Amsterdam, The Netherlands 1997.
  • 26
    Lenti C, Masserini C, Peruzzi C, Guareschi CA. Effects of carbamazepine and valproate on immunological assessment in young epileptic patients. Ital J Neurol Sci 1991; 12: 8791.
  • 27
    De Sarro GB, Berlinghieri MC, Elia M et al. Does antiepileptic therapy affect immune response? J Chemother 1998; 10: 1846.